These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38136312)

  • 81. TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher.
    Lu T; Li Y; Pan M; Yu D; Wang Z; Liu C; Hu G
    Int J Biol Sci; 2022; 18(5):1795-1812. PubMed ID: 35342354
    [No Abstract]   [Full Text] [Related]  

  • 82. LncRNA SELL/L-selectin promotes HPV-positive HNSCC progression and drives fucoidan-mediated therapeutic strategies.
    Wang S; Pang X; Tong L; Fan H; Jiang J; Zhao M; Yu X; Li M; Liang J; Fan Y; Zhang X; Tang Y; Sun Y; Liang X
    Acta Biomater; 2023 Sep; 167():436-448. PubMed ID: 37330030
    [TBL] [Abstract][Full Text] [Related]  

  • 83. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma.
    Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y
    J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.
    Fukusumi T; Guo TW; Ren S; Haft S; Liu C; Sakai A; Ando M; Saito Y; Sadat S; Califano JA
    Int J Oncol; 2021 Feb; 58(2):226-237. PubMed ID: 33491747
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.
    Wakasaki T; Masuda M; Niiro H; Jabbarzadeh-Tabrizi S; Noda K; Taniyama T; Komune S; Akashi K
    Neoplasia; 2010 Oct; 12(10):789-96. PubMed ID: 20927317
    [TBL] [Abstract][Full Text] [Related]  

  • 87. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.
    Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W
    Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142
    [No Abstract]   [Full Text] [Related]  

  • 88. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
    Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
    Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diagnostic and prognostic significance of lncRNA SOX2-OT in patients with carotid atherosclerosis.
    Tao J; Hu Y
    BMC Cardiovasc Disord; 2022 May; 22(1):211. PubMed ID: 35538435
    [TBL] [Abstract][Full Text] [Related]  

  • 90. SEC11A contributes to tumour progression of head and neck squamous cell carcinoma.
    Shen H; Yi F; Ding Z; Liu W; Liu P; Wang Z; Liu S; Liu Y; Li D
    Heliyon; 2023 Apr; 9(4):e14958. PubMed ID: 37025806
    [TBL] [Abstract][Full Text] [Related]  

  • 91. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
    Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
    Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
    Nohata N; Abba MC; Gutkind JS
    Oral Oncol; 2016 Aug; 59():58-66. PubMed ID: 27424183
    [TBL] [Abstract][Full Text] [Related]  

  • 93. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma.
    Wang Y; Wang S; Ren Y; Zhou X
    Front Oncol; 2020; 10():561833. PubMed ID: 33123473
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
    Li J; Shi C; Zhou R; Han Y; Xu S; Ma H; Zhang Z
    Cancer Sci; 2020 Sep; 111(9):3222-3235. PubMed ID: 32589311
    [TBL] [Abstract][Full Text] [Related]  

  • 96. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex.
    Li D; Shen L; Zhang X; Chen Z; Huang P; Huang C; Qin S
    J Exp Clin Cancer Res; 2022 Dec; 41(1):332. PubMed ID: 36457025
    [TBL] [Abstract][Full Text] [Related]  

  • 97. LncRNA TM4SF19-AS1 exacerbates cell proliferation, migration, invasion, and EMT in head and neck squamous cell carcinoma via enhancing LAMC1 expression.
    Yu Z; Wang X; Niu K; Sun L; Li D
    Cancer Biol Ther; 2022 Dec; 23(1):1-9. PubMed ID: 36411963
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
    Li J; Liu X; Nan S; Xu C
    Free Radic Res; 2020 Apr; 54(4):254-270. PubMed ID: 32462956
    [TBL] [Abstract][Full Text] [Related]  

  • 99. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
    Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
    Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence.
    Barbosa S; Laureano NK; Hadiwikarta WW; Visioli F; Bonrouhi M; Pajdzik K; Conde-Lopez C; Herold-Mende C; Eidt G; Langie R; Lamers ML; Stögbauer F; Hess J; Kurth I; Jou A
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.